BioLargo, Inc.
BLGO
$0.22
$0.01537.47%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.91% | -88.83% | -21.77% | -7.56% | 43.76% |
| Total Depreciation and Amortization | 26.87% | -1.47% | 13.33% | 46.34% | -53.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -129.95% | 208.50% | -198.52% | -21.62% | -72.03% |
| Change in Net Operating Assets | 39.04% | -24.71% | -3,622.22% | -95.43% | 305.92% |
| Cash from Operations | 4.49% | -18.27% | -972.85% | -131.39% | 24,150.00% |
| Capital Expenditure | -- | 164.10% | 89.11% | 58.52% | -491.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -46.15% | 89.11% | 58.52% | -491.10% |
| Total Debt Issued | -31.71% | -- | -- | -- | -- |
| Total Debt Repaid | -100.00% | 50.00% | -33.33% | 40.00% | -109.09% |
| Issuance of Common Stock | -- | -- | -23.35% | -7.90% | 79.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.75% | -- | -- | -- | -- |
| Cash from Financing | -45.60% | 108.38% | -23.52% | -7.76% | 42.31% |
| Foreign Exchange rate Adjustments | -142.55% | 291.67% | 119.67% | -163.54% | 182.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -194.61% | 62.17% | -305.83% | -46.17% | 60.36% |